Exponent, Inc. (EXPO) Tops Q1 EPS by 4c, provides outlook

Exponent, Inc. (NASDAQ: EXPO) reported Q1 EPS of $0.52, $0.04 better than the analyst estimate of $0.48. Revenue for the quarter came in at $145.51 million versus the consensus estimate of $136.93 million.

For the second quarter of fiscal 2025 as compared to the same period one year prior, Exponent anticipates:

Revenues before reimbursements to be down in the low-single digits; and,
EBITDA1 to be 26.0% to 27.0% of revenues before reimbursements.

For earnings history and earnings-related data on Exponent, Inc. (EXPO) click here.

You May Also Be Interested In

• BofA maintains underperform ratings on six BDC stocks
• Nuvectis Pharma (NVCT) files $200M mixed shelf
• Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders